✦ LIBER ✦

Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer

Book ID: 123515227
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 146 KB
Volume: 6
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(90)90310-I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Properties of recombinant interleukin 2-

✍ Tokujiro Yano; Kosei Yasumoto; Masatoshi Togami; Teruyoshi Ishida; Genki Kimura; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 532 KB

Natural killer activity of lymphocytes i

Natural killer activity of lymphocytes infiltrating human lung cancers following preoperative systemic recombinant interleukin 2

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Time course of changes in phenotypes of

Time course of changes in phenotypes of cultured tumor-infiltrating lymphocytes isolated from human colorectal cancer

✍ Shimazaki, Makoto ;Ninomiya, Mitsuo ;Muto, Yasutoshi ;Saito, Koshiro ;Moriwaki, 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 510 KB

TUMOUR-INFILTRATING LYMPHOCYTES AND INTE

TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER

✍ Kradin, RichardL.; Lazarus, DavidS.; Dubinett, StevenM.; Gifford, Julie; Grove, 📂 Article 📅 1989 🏛 The Lancet 🌐 English ⚖ 643 KB

Culture of human tumor infiltrating lymp

Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors

✍ Richard A. Knazek; Yan-Wan Wu; Paul M. Aebersold; Steven A. Rosenberg 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 710 KB

Role of tumor-infiltrating lymphocytes i

Role of tumor-infiltrating lymphocytes in the host defense mechanism against lung cancer

✍ Kosei Yasumoto; Sadanori Takeo; Tokujiro Yano; Hisashi Nakahashi; Akira Nagashim 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Tumor-infiltrating lymphocytes (TIL) and tumor-associated macrophages (TAM) were recovered from 22 patients with primary lung cancer. The TIL did not exhibit any cytolytic activity against various target cells. The average percentage of TIL recovered was 6.7 f 1.3% in patients without recurrence, as